CTOs on the Move

Coastal Life Systems Inc USA

www.cltsa.com

 
Coastal Life Systems Inc USA is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.cltsa.com
  • 1803 Grandstand Dr Ste 101
    San Antonio, TX USA 78238
  • Phone: 210.684.3454

Executives

Name Title Contact Details

Similar Companies

DMC - PHO

DMC - PHO is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GendelLindheim BioCom Partners

GendelLindheim BioCom Partners is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Syndicus

Since its beginning in 2007 as a technical staffing and business solutions group in Annapolis, Md., Syndicus has evolved into a highly respected technical staffing and consulting solutions group that provides talent and solutions for three focus areas: Health Information Technology, Life Sciences Solutions and Technology Services. We pride ourselves in partnering with top subject matter experts who ensure candidates, consultants and solutions meet clients' specialized needs. In 2012, Syndicus achieved both a full national accreditation with the Management Services Organization Accreditation Program (MSOAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC) and the MSO State Designation from the Maryland Health Care Commission (MHCC). The two certifications enable Syndicus and its electronic health records (EHR) hosted solutions provider eCast Corporation to continue working with Maryland healthcare providers on EHR adoption efforts – and subsequent achievement of Meaningful Use.

Geron

We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.

Baby and Company

At Baby+Company we want to change the world one birth at a time… We`re driven by a passion to expand women`s choices -to make what can feel like a choice between two extremes, hospital delivery and home birth, into a spectrum of options. Not because we don`t support these other models of care, but because for many women, neither feels like the right fit. So we`re building birth centers that celebrate the individuality of our families— through a model of care that brings together the centuries-old tradition of midwifery with the very best research, resources and data available today.